Compare Eos Energy Enterprises Inc (EOSE) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Eos Energy Enterprises IncTrade

Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Eos Energy Enterprises Inc vs Neurocrine Biosciences Inc — how do they compare? Eos Energy Enterprises Inc trades at $4.18 (market cap $1.55B), while Neurocrine Biosciences Inc trades at $171.81 (market cap $17.30B). The key difference: Neurocrine Biosciences Inc is far larger — about 11.2× Eos Energy Enterprises Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Eos Energy Enterprises Inc nearer its low. Which is the better fit depends on your goals.

	EOSE	NBIX
Market Cap	$1.55B	$17.30B
Sector	Energy	Health
52-Week High	$19.19	$180.55
52-Week Low	$4.29	$123.10
Enterprise Value	$1.79B	$16.39B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eos Energy Enterprises Inc

Eos Energy Enterprises (EOSE) trades at $4.21, down 1.86% on the day, amid a bearish technical signal. The company reported a net loss of $969.65 million on $114.20 million revenue in 2025, with negative gross and net profit margins, but revenue growth is accelerating into 2026. Recent news highlights record quarterly revenue expectations and a $125 million investment for Frontier Power USA, signaling strong commercial momentum.

The outlook is mixed: accelerating revenue and a growing project backlog offer upside potential, but persistent losses and high debt-to-asset ratio of 91.87% pose significant financial risks. Analyst consensus is a 'Hold' with a $9.00 price target, reflecting cautious optimism balanced by execution concerns in the competitive energy storage market.

Neurocrine Biosciences Inc

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EOSE

Eos Energy wins contract to supply zinc-based energy storage for US defense's Golden Dome projectGlobeNewsWire · 21 hours agoBullish Eos Energy expects record Q2 2026 revenue of $68-69M and backlog of $807M, driven by manufacturing scale-up.GlobeNewsWire · 1 day agoBullish Frontier Power USA selects 400 MWh Wildfire BESS project, nearing 90% of 2 GWh battery capacity deal with Eos.GlobeNewsWire · 2 days agoBullish View details →

NBIX

View details →

About Eos Energy Enterprises Inc

Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.